A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1997
05/22/1997	WO1997017970A1 Kainic acid neuronotoxicity inhibitors and pyridothiazine derivatives
05/22/1997	WO1997017969A1 Dihydropyrimidines and uses thereof
05/22/1997	WO1997017968A1 Hemoregulatory compounds
05/22/1997	WO1997017967A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
05/22/1997	WO1997017966A1 Hemoregulatory compounds
05/22/1997	WO1997017965A1 Hemoregulatory compounds
05/22/1997	WO1997017964A1 Hemoregulatory compounds
05/22/1997	WO1997017963A1 Hemoregulatory compounds
05/22/1997	WO1997017962A1 Method for treating anxiety
05/22/1997	WO1997017961A1 Hemoregulatory compounds
05/22/1997	WO1997017960A1 Pharmaceutical composition comprising amoxycillin and clavulanate and a desiccant
05/22/1997	WO1997017959A1 Hemoregulatory compounds
05/22/1997	WO1997017958A1 Hemoregulatory compounds
05/22/1997	WO1997017957A1 Hemoregulatory compounds
05/22/1997	WO1997017956A1 Method for treating anxiety
05/22/1997	WO1997017955A1 Method for treating anxiety
05/22/1997	WO1997017954A1 Analgesic compounds and uses thereof
05/22/1997	WO1997017953A1 Method for the treatment, prevention or minimization of hair loss using a source of fatty acids
05/22/1997	WO1997017952A1 Excitatory amino acid receptor antagonists
05/22/1997	WO1997017951A1 Stabilized thyroid hormone preparations and methods of making same
05/22/1997	WO1997017950A1 Shoulder prosthesis
05/22/1997	WO1997017949A1 Benzamidoxime prodrugs as antipneumocystic agents
05/22/1997	WO1997017948A1 Formulation for respiratory tract administration
05/22/1997	WO1997017947A1 Directly compressible high load acetaminophen formulations
05/22/1997	WO1997017946A2 Method and device for producing a parenteral medicament
05/22/1997	WO1997017943A1 Improved pseudocatalase composition
05/22/1997	WO1997017937A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
05/22/1997	WO1997017851A1 Hemoregulatory compounds
05/22/1997	WO1997017850A1 Hemoregulatory compounds
05/22/1997	WO1997010800A3 Antiplaque oral composition
05/22/1997	WO1997009976A3 Method of reducing neurotoxic injury with zinc chelators
05/22/1997	WO1997005241A3 Methods and compositions for identifying morphogen analogs
05/22/1997	WO1996040262A3 Process for preparing encapsulated water soluble beta-carotene
05/22/1997	WO1996036330A3 Compositions containing fatty acids for improving digestion and absorption in the small intestine
05/22/1997	DE19633444A1 Use of allicin-urotropin product at high dilution
05/22/1997	DE19542854A1 Verwendung von Esuprone zur Behandlung von Angst und angstartigen Zuständen Use of Esuprone used to treat anxiety and fear-like states
05/22/1997	DE19542499A1 Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung Method and apparatus for preparing a parenteral drug formulation
05/22/1997	CA2549534A1 Benzamidoxime prodrugs as antipneumocystic agents
05/22/1997	CA2240192A1 Methods for screening compounds that modulate cholesterol transport
05/22/1997	CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r)
05/22/1997	CA2237998A1 Chemokine from niddm pancreas
05/22/1997	CA2237997A1 Antimalarial quinolin derivatives
05/22/1997	CA2237911A1 Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative
05/22/1997	CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
05/22/1997	CA2237774A1 Dihydropyrimidines and uses thereof
05/22/1997	CA2237758A1 Topical compositions containing a beta-cyclodextrin and an amino polysaccharide
05/22/1997	CA2237598A1 Excitatory amino acid receptor antagonists
05/22/1997	CA2237565A1 Improved method and agents for inhibiting protein aging
05/22/1997	CA2237558A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
05/22/1997	CA2237528A1 Chimeric oligomers having an rna-cleavage activity
05/22/1997	CA2237524A1 Novel macrocyclic compounds as metalloprotease inhibitors
05/22/1997	CA2237404A1 Excitatory amino acid receptor antagonists
05/22/1997	CA2237400A1 Methods of treating disorders of non-visual sensory epithelia
05/22/1997	CA2237384A1 Analgesic compounds and uses thereof
05/22/1997	CA2237361A1 Improved pseudocatalase composition
05/22/1997	CA2237311A1 Method for treating anxiety
05/22/1997	CA2237220A1 Method for treating anxiety
05/22/1997	CA2236832A1 Substituted piperidine derivatives as selective agonists of 5-ht receptors
05/22/1997	CA2236773A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
05/22/1997	CA2236594A1 Method for treating anxiety
05/22/1997	CA2236236A1 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/22/1997	CA2235855A1 Morpholine derivatives and their use as therapeutic agents
05/22/1997	CA2235707A1 Stabilized thyroid hormone preparations and methods of making same
05/22/1997	CA2235695A1 Inducing resistance to tumor growth with soluble igf-1 receptor
05/22/1997	CA2235394A1 Anti-viral isolates obtainable from leeches
05/22/1997	CA2235370A1 Alpha 1a adrenergic receptor antagonists
05/22/1997	CA2235126A1 Quinoline derivatives as type iv phosphodiesterase inhibitors
05/22/1997	CA2234661A1 Mimotopes and anti-mimotopes of human platelet glycoprotein ib/ix
05/22/1997	CA2232876A1 Fas ligand fusion protein
05/21/1997	EP0774466A1 Novel cephem derivatives
05/21/1997	EP0774465A1 Penem derivatives and antimicrobial agents containing the same
05/21/1997	EP0774459A1 Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing them
05/21/1997	EP0774458A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent
05/21/1997	EP0774457A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent
05/21/1997	EP0774455A1 Excitatory amino acid receptor antagonists
05/21/1997	EP0774454A1 Excitatory amino acid receptor antagonists
05/21/1997	EP0774259A1 New use of organic compounds
05/21/1997	EP0774258A1 Composition containing 5-fluorouracil and d4T for use in the treatment of retroviral infection
05/21/1997	EP0774257A2 Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration
05/21/1997	EP0774256A1 Use of azacyclic or azabicyclic thiadiazole compounds for treating anxiety
05/21/1997	EP0774255A1 Use of ursolic acid for the manufacture of a medicament for suppressing metastasis
05/21/1997	EP0774254A1 Pharmaceutical composition for preventing or treating dry eye or disease caused thereby comprising 12-sulfodehydroabietic acid
05/21/1997	EP0774253A1 Paracetamol and metoclopramide containing pharmaceutical compositions with anti-migraine activities
05/21/1997	EP0774252A1 Cytokine potentiator and remedy for diseases wherein cytokine activity is reduced
05/21/1997	EP0774251A2 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
05/21/1997	EP0774250A1 Use of a TNF alpha antagonist against skin redness of neurogenic origin
05/21/1997	EP0774249A2 Topical composition containing specific flavanones
05/21/1997	EP0774008A1 Adenovirus including a gene coding for a superoxide dismutase
05/21/1997	EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy
05/21/1997	EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
05/21/1997	EP0773965A2 Gas phase production of polydienes
05/21/1997	EP0773964A1 Gas phase production of polydienes
05/21/1997	EP0773963A1 Gas phase polymerization process
05/21/1997	EP0773955A1 New thrombin inhibitors, their preparation and use
05/21/1997	EP0773951A1 Dinucleoside-5',5'-pyrophosphates
05/21/1997	EP0773950A1 Linked peptide nucleic acids
05/21/1997	EP0773949A1 D-mannose or xylitol esters and their use as drugs
05/21/1997	EP0773947A1 5H-THIAZOLO 3,2-a]PYRIMIDIN-5-ONE DERIVATIVES
05/21/1997	EP0773946A1 Imidazopyridine-azolidinones
05/21/1997	EP0773945A1 Acyl imidazopyridines

1 ... 6793 6794 6795 6796 6797 6798 6799 6800 6801 6802 6803 6804 6805 6806 6807 6808 6809 6810 6811 6812 6813 ... 7860